Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuronetics (STIM) Invested Capital (2017 - 2025)

Historic Invested Capital for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to $32.4 million.

  • Neuronetics' Invested Capital rose 24495.26% to $32.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.4 million, marking a year-over-year increase of 24495.26%. This contributed to the annual value of $32.8 million for FY2024, which is 406.84% down from last year.
  • As of Q3 2025, Neuronetics' Invested Capital stood at $32.4 million, which was up 24495.26% from $32.5 million recorded in Q2 2025.
  • In the past 5 years, Neuronetics' Invested Capital ranged from a high of $126.2 million in Q3 2021 and a low of $9.4 million during Q3 2024
  • In the last 5 years, Neuronetics' Invested Capital had a median value of $45.5 million in 2023 and averaged $56.6 million.
  • Per our database at Business Quant, Neuronetics' Invested Capital plummeted by 7527.48% in 2024 and then skyrocketed by 24495.26% in 2025.
  • Neuronetics' Invested Capital (Quarter) stood at $85.2 million in 2021, then dropped by 17.6% to $70.2 million in 2022, then crashed by 51.29% to $34.2 million in 2023, then dropped by 4.07% to $32.8 million in 2024, then decreased by 1.34% to $32.4 million in 2025.
  • Its Invested Capital stands at $32.4 million for Q3 2025, versus $32.5 million for Q2 2025 and $40.5 million for Q1 2025.